Orphazyme A/S - ADR Financials

$0.15

$-0.19 (-55.61%)

As on 26-May-2022 09:30EDT

Market cap

$37 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.2

Div. Yield

0 %

Annual
Quarterly

Income Statement (Kr. Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	--	608.53	335.95	231.65	131.04	63.52
Operating Profit (EBIT)	-181.49	-608.53	-335.95	-231.65	-131.04	-63.52
Other Income	--	--	--	--	--	--
Profit before Tax	-190.88	-635.16	-343.00	-235.10	-131.70	-63.44
Provision for Tax	-2.25	-1.92	-5.50	-5.50	-5.50	-5.50
Profit after Tax (Net Income)	-190.92	-633.25	-337.50	-229.60	-126.20	-57.94
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-845.61	-633.25	-337.50	-229.60	-126.20	-57.94

Liabilities (Kr. Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	166.76	620.53	52.97	388.25	615.70	17.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	37.61	35.34	61.80	0.11	--	--
Current Liabilities	223.66	166.63	65.99	53.00	47.12	14.43
Total Liabilities	651.69	822.49	180.75	441.35	662.82	31.94

Assets (Kr. Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	24.34	38.83	32.53	17.97	14.86	4.05
Current Assets	403.70	783.66	148.23	423.38	647.95	27.89
Total Assets	651.69	822.49	180.75	441.35	662.82	31.94
Total Debt*	58.59	70.71	77.11	--	--	--
Net Current Assets	180.04	617.04	82.24	370.39	600.84	--

Cashflow (Kr. Mln)	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	--	-539.08	-326.82	-234.76	-95.43	-54.73
Cash Flow from Investing Activities	--	-5.10	-3.29	-2.35	-1.49	-0.24
Cash from Financing Activities	--	1,159.42	58.94	58.94	714.30	1.30
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS (Kr.)	--	--	--	--	--	--
Cash EPS (Kr.)	--	--	--	--	--	--
Adjusted Book Value (Kr.)	--	--	--	--	--	--
Dividend per Share (Kr.)	--	--	--	--	--	--
Cash Flow per Share (Kr.)	--	--	--	--	--	--
Free Cash Flow per Share (Kr.)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	--	--	-154.20	-130.23	-45.74	-39.86
ROE (%)	--	--	-188.05	-152.98	-45.74	-39.86
ROA (%)	--	-26.34	-126.24	-108.50	-41.59	-36.33
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	-217.19	-81.30	-44.93	-76.72	-106.36
Net Profit Growth (%)	--	-51.87	-87.63	-46.99	-81.93	-117.84
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	--	0.08	0.11	1.46	--	--
Short term debt to equity ratio	--	0.22	0.06	0.30	--	--
Current Ratio	--	1.80	4.70	2.25	7.99	13.75
Quick Ratio	--	1.80	--	--	--	--
Interest Coverage	--	-16.98	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.